Melatonin for Parkinson's patients on levodopa
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests if adding melatonin can reduce oxidative stress (a kind of cell damage) in people with mild to moderate Parkinson's disease who are already taking levodopa. It aims to see if melatonin helps protect the brain and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Parkinson's disease and currently take levodopa
- Your Parkinson's is mild to moderate (stages I, II, or III on a common scale)
- You are older than 45
- You are not pregnant, breastfeeding, or planning to become pregnant
- You do not have certain other health issues like autoimmune disease or active cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether regular light therapy can help people with Parkinson's disease. It is designed for patients whose symptoms are at a moderate stage and whose medication has been stable for a month or more.
This trial tests if metformin, a diabetes drug, can help people with Parkinson's disease. It may improve symptoms or slow progression.
This Phase 2 study tests whether melatonin can improve sleep and possibly outcomes related to diabetic retinopathy (damage to the retina from diabetes). It also checks whether it affects related symptoms while keeping people safe.
This study tests whether a special light therapy, called flash stimulation, can help people with Parkinson's disease sleep better and feel better during the day. If you have Parkinson's and sleep problems, this treatment might be a new option for you.
This study tests whether taking 5 mg of melatonin can improve thinking and brain health over time in older adults with early, mild symptoms. You may help researchers learn which brain changes and measures improve with melatonin.
This trial tests a sleep medication called lemborexant in people with Parkinson's disease who also have insomnia. The goal is to see if it improves both sleep and movement symptoms.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.